Home » Newsletters » BioWorld Science

BioWorld Science

June 5, 2020

View Archived Issues

EZH2 has dual role

Imitating ticks to evade immunity

ValiRx collaborates with Oncolytika and Black Cat Bio to explore combination treatment for COVID-19

Inovio and partners to initiate phase I/II study of COVID-19 DNA vaccine in South Korea

Intravacc announces partnership to develop intranasal COVID-19 vaccine

IRLAB announces preparations for phase IIb/III study of mesdopetam in PD

PharmAust reports preliminary data for monepantel in models of SARS-CoV-2 infection

CytomX presents first-in-human data for CX-2029

Onconova Therapeutics describes multi-specific protein kinase inhibitors

Type-1 angiotensin II receptor antagonists discovered at MFC

Forge Therapeutics patents bacterial LpxC inhibitors

New JAK1 inhibitors identified at HK inno.N Corp.

Phase I data for mRNA-2752 as monotherapy or in combination with durvalumab

Nippon Shinyaku discovers pim-1 kinase inhibitors

Selective TREK channel activator alleviates pain in mice without opioid-like adverse effects

Identification of inhibitors of the main protease of SARS-CoV-2

Results presented for GC-1118 with irinotecan or FOLFIRI in patients with metastatic solid tumors

Meiji Seika Pharma discontinues development of ME-1111 for treatment of onychomycosis

Phase III STEP 1 trial of semaglutide in obesity meets primary endpoints

Molecular pair offers potential Parkinson's treatment

FDA places clinical hold on phase II/III trial of LYS-SAF-302 gene therapy for MPS IIIA

FDA approves Recarbrio for hospital-acquired and ventilator-associated bacterial pneumonia

FDA clears IND for phase I/II trial of autologous cell therapy EXG-34217

Anti-PD-1 MAb zimberelimab shows promise in patients with recurrent or metastatic cervical cancer

PDS Biotechnology announces phase II trial of PDS-0101 with chemoradiotherapy for cervical cancer

DMX-200 to be studied for COVID-19 within REMAP-CAP program

CEPI supports development of BBV-87 vaccine against Chikungunya

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...